Skip to main content

Table 1 Characteristics of women ≥29 years who sought cervical cancer screening services through NJCEED, overall and among those who ever had a high-risk human papilloma virus (HR-HPV) DNA test and those who ever received a positive HR-HPV test result, 2009–2015

From: Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women

Patient-level characteristics Total, N = 50,510 Ever had a HR-HPV DNA test, n = 13,440*   Ever received a positive HR-HPVtest result, n = 1792**  
n (%) n (%) P a n (%) P b
Sociodemographics
 Age at enrollment into NJCEED (years)    < 0.001   < 0.001
  29–39 7987 (15.8) 2457 (18.3)   532 (29.7)  
  40–49 19,909 (39.4) 5663 (42.1)   689 (38.4)  
   ≥ 50 22,614 (44.8) 5320 (39.6)   571 (31.9)  
 Race/ethnicity    < 0.001   < 0.001
  Non-Hispanic White 12,420 (24.6) 2706 (20.1)   443 (24.7)  
  Non-Hispanic Black 7716 (15.3) 1993 (14.8)   247 (13.8)  
  Asian/Pacific Islander 3351 (6.6) 1060 (7.9)   98 (5.5)  
  Hispanic 27,023 (53.5) 7681 (57.2)   1004 (56.0)  
 Place of birth    < 0.001   < 0.001
  USA 14,695 (29.1) 3468 (25.8)   525 (29.3)  
  Central and South America 20,437 (40.5) 5575 (41.5)   754 (42.1)  
  Caribbean 7266 (14.4) 2007 (14.9)   261 (14.6)  
  Africa 952 (1.9) 243 (1.8)   19 (1.1)  
  Asia and the Middle East 3283 (6.5) 1075 (8.0)   95 (5.3)  
  Europe, Russia and Australia and Oceania 1549 (3.1) 546 (4.1)   61 (3.4)  
  Other countriesc 2328 (4.6) 526 (3.9)   77 (4.3)  
Cervical cancer screening characteristics
 Number of cervical screening visits    < 0.001   < 0.001
  1 29,872 (59.1) 7399 (55.1)   842 (47.0)  
  2 8760 (17.3) 2488 (18.5)   356 (19.9)  
   ≥ 3 11,878 (23.5) 3553 (26.4)   594 (33.1)  
 Number of Pap tests    < 0.001   
  0 1571 (3.1) 10 (0.1)   4 (0.2)  
  1 35,670 (70.6) 8488 (63.2)   967 (54.0)  
  2 8347 (16.5) 2717 (20.2)   379 (21.1)  
   ≥ 3 4922 (9.7) 2230 (16.6)   442 (24.7)  
 Age at first Pap test (years)    < 0.001   
  29–39 7778 (15.9) 2450 (18.2)   529 (29.6)  
  40–49 19,291 (39.4) 5658 (42.1)   688 (38.5)  
   ≥ 50 21,870 (44.7) 5322 (39.6)   571 (31.9)  
 Number of HPV tests    < 0.001   < 0.001
  0 37,070 (73.4) 0 (0.0)   0 (0.0)  
  1 11,810 (23.4) 11,810 (87.9)   1391 (77.6)  
  2 1386 (2.7) 1386 (10.3)   306 (17.1)  
   ≥ 3 244 (0.5) 244 (1.8)   95 (5.3)  
 Age at first HPV test (years)     < 0.001
  29–39   2307 (17.2)   514 (28.7)  
  40–49   5461 (40.6)   673 (37.6)  
   ≥ 50   5672 (42.2)   605 (33.8)  
  1. Abbreviations: FPL federal poverty level, HR-HPV high-risk human papillomavirus, NJCEED New Jersey Cancer Early Education and Detection, USA United States of America, ZCTA ZIP Code Tabulation Area. Bolded values represent statistically significant associations (P <0.05)
  2. *Of the 50,510 NJCEED patients ≥29 years included in the analytic sample, 13,440 (26.6%) had at least one HR-HPV DNA test
  3. **Of the 13,440 NJCEED patients ≥29 years included in the analytic sample, 1792 (13.3%) had at least one positive HR-HPV DNA test result
  4. aP-values were calculated using chi-square tests comparing women who ever had a HR-HPV DNA test to those who did not
  5. bP-values were calculated using chi-square tests comparing women who ever had a positive HR-HPV DNA test result to those who did not
  6. cIncludes women born in Canada as well as those reporting other or unspecified countries outside the USA